“Economic evaluation of temsirolimus on the basis of the results of the ARCC (Advanced Renal-Cell Carcinoma) study” (2009) Farmeconomia. Health Economics and Therapeutic Pathways, 10(2), pp. 93–97. doi:10.7175/fe.v10i2.167.